Discussion with the audience, session 2
- Joao Albuquerque Silva, European Commission -Carlos Malpica, MLP Vision Biotech S.L , Madrid, Spain - Diarmuid O'Brien, Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN), Dublin, Ireland -A?sa Wheelock, Assistant professor, Kar